Fixed-effects panel regression results for nicotine dependence drug prescribing. by Dainty Ei (22265317)

Subjects:

The incidence and mortality data of LC by age group from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

A) Right-hand layup gesture. B) Left-hand layup gesture. by María Benito-de-Pedro (22057468)

Subjects:

Approximate X(x,y) for different value of and for test problem 3. by Lahoucine Tadoummant (21647670)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2021. by Dainty Ei (22265317)

Subjects:

Results of the linear models for the amplitudes (in <i>μ</i>V) of the components P1, N1, P2, and N400. by Elena Bolt (20396190)

Subjects:

(a) Absolute error of the example 3, X(x,y) for scale level ranging from 2 to 7. by Lahoucine Tadoummant (21647670)

Subjects:

Population as of 1 November, number by age, sex, year, and region. by Dainty Ei (22265317)

Subjects:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). by Michael C. Payne (2664379)

Subjects:

Participant Clinical and Demographic Characteristics. by Yanin Suwan (4752099)

Subjects:

Results of the generalized linear mixed model (GLMM) for correct responses in the speech recognition task. by Elena Bolt (20396190)

Subjects:

Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Directly observed antifilarial drug ingestion rates in semiannual and annual mass drug administration (MDA) areas. by Michael C. Payne (2664379)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2020. by Dainty Ei (22265317)

Subjects:

Placement of surface electrodes according to SENIAM protocol. by María Benito-de-Pedro (22057468)

Subjects:

Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

Subjects:

MoCA scores distribution and audiometry results for participants. by Elena Bolt (20396190)

Subjects:

Contribution of changes in population aging, population growth, and age-specific incidence rate to changes in incident cases of LC from 2004 to 2018 in China. by Ze-Xing Zhang (18074512)

Subjects:

Additional questions on vaccination. by Sara Saleh (6733619)

Subjects: